Clinical TrialsA clinical trial (also called an interventional study or clinical study) is a research study conducted to answer specific questions about a new treatment or a new way of using an existing treatment. Participation in a clinical study contributes to medical knowledge. The investigators in clinical trials want to determine the safety and effectiveness of the treatment being investigated by making specific assessments, before, during, and after the trial. In general, clinical studies are designed to add to medical knowledge related to the treatment, diagnosis, and prevention of diseases or conditions. Some common reasons for conducting clinical studies include:
Hundreds of lymphoma clinical trials are being conducted at hospitals, cancer centers, and doctors' offices, often sponsored by the government, pharmaceutical companies, universities, and physician groups.Your decision to participate in a cancer trial is an individual decision that should be made with your doctor after careful consideration of all of the potential risks and benefits. You may choose to discontinue participation in a clinical trial at any time. For more information, please see LRF's Understanding Clinical Trials Fact Sheet
Clinical Trials Information ServiceThe Lymphoma Research Foundation (LRF) provides a Clinical Trials Information Service to increase awareness about investigational treatments for lymphoma being evaluated at cancer treatment centers nationwide. LRF does not provide medical advice or endorse specific treatments; however, upon request, the Helpline staff will conduct a search for potential lymphoma treatment trials based upon medical information that you provide. You are strongly encouraged to discuss with your physician the summaries emailed or mailed to you by LRF. Your cancer specialist will be familiar with your medical history and can best evaluate all of the study criteria to determine if the clinical trial is appropriate for you.
Information that is requested in order to perform the clinical trials search is:
2. Diagnosis (lymphoma subtype)
3. Types of previous treatment (if any), the dates and the response
4. Other medical diagnosis (i.e., another cancer, HIV, pregnancy)
5. Geographic area willing to travel to for treatment
Hundreds of lymphoma clinical trials are being conducted at hospitals, cancer centers, and doctors' offices, often sponsored by the government, pharmaceutical companies, universities, and physician groups. The U.S. Food and Drug Administration, as well as the Institutional Review Board of the participating hospital or institution must approve each clinical trial phase. Your decision to participate in a cancer trial is an individual decision that should be made with your doctor after careful consideration of all of the potential risks and benefits. You may choose to discontinue participation in a clinical trial at any time. For more general information, please:
LRF makes reasonable efforts to search publicly posted trials, but cannot guarantee that the trials provided are entirely comprehensive or that you will in fact meet all eligibility criteria. Not all study sponsors post their clinical trial information on public databases, so there is no entirely comprehensive listing. Clinical trials information is updated frequently. LRF cannot be held responsible for any consequences or damages arising from the use of this information. This service is governed by the term and conditions of the website.
Resources for Clinical Trials and SearchesThe National Institutes of Health (NIH)
This site, sponsored by the National Library of Medicine and the National Institutes of Health includes hundreds of lymphoma trials sponsored by the NCI, health institutions and the pharmaceutical industry, with links to published medical literature. The goal of this Web site is to offer a comprehensive clinical trial resource that is easy to navigate. Under the resources section of this site are links for information on clinical trials, how to participate in a study, a glossary of clinical trial terms, and links for other resources.
The National Cancer Institute (NCI)
Although this site shares clinical trial summaries with the above www.clinicaltrials.gov website, the search process is different and may be preferred by some. Trial summaries are in two versions, one for patients and another for healthcare professionals. Also found here are many resources including listing recent developments and results; an overview for learning about clinical trials; and a comprehensive step by step detail on finding a clinical trial. Finally the NCI's Information Service at 800-4-CANCER is available to provide more information on clinical trials and to request educational materials.